Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 2.590
+0.010 (0.39%)
Nov 11, 2026, 12:13 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 99.29 million as of November 10, 2026. It is the 23,717th most valuable company in the world and the 178th biggest in Switzerland. Its market cap has decreased by 19.31% in one year.
Market Cap
99.29M
Enterprise Value
44.54M
Revenue
n/a
Global Rank
Country Rank
#178 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 99.29M, a decrease of -76.70%. That is a compound annual growth rate of -11.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 99.29M | -21.57% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.98B |
| Idorsia | 1.11B |
| Basilea Pharmaceutica AG | 882.25M |
| Santhera Pharmaceuticals Holding AG | 226.85M |
| Newron Pharmaceuticals | 193.27M |
| BioVersys AG | 137.84M |
| Xlife Sciences AG | 47.87M |
| MindMaze Therapeutics Holding | 23.87M |